Full-Text Search:
Home|About CNKI|User Service|中文
Add to Favorite Get Latest Update

Clinical Progress on Bortezomib in the Treatment for Multiple Myeloma

TAN Ya-min, HUANG He (The Affiliated First Hospital of Medical College, Zhejiang University, Hangzhou 310006, China)  
Bortezomib is a new proteasome inhibitor. Clinical studies demonstrat that bortezomib plays role in the treatment for relapsed, refractory and initially treated multiple myeloma. Clinical progress on bortezomib in the treatment for multiple myeloma was reviewed.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©CNKI All Rights Reserved